InvestSMART

Enlitic Inc (ASX:ENL)

ALERT: Price-sensitive ASX Announcement for ENL
Current share price for ENL : $0.006 0.001 (20%)+
Announcement
Release
3 Jul 2026 9:37AM
Price at Release
$0.005
Full Release
download
Summary
Enlitic Inc.'s investor presentation focused on capital raising and the conversion of convertible notes outlines a strategy to raise approximately A$15 million through the issuance of new CHESS Depositary Interests, pending shareholder approval. The funds aim to support commercialization, scale-up sales, marketing efforts, and ensure operational sustainability through to cash flow break-even. The company has established a significant growth trajectory with a robust distribution network across 15 countries and aims to expand its SaaS offerings. Enlitic is committed to transforming healthcare data governance to support AI deployment, addressing the critical need for trustworthy and auditable data in healthcare operations. The transaction will result in a fully funded business with no debt, and a recapitalized balance sheet, positioning Enlitic to leverage its established partnerships with leading healthcare systems to further grow its SaaS revenue base.
Key Points
  • Capital raising of ~A$15 million through new CHESS Depositary Interests.
  • Conversion of convertible notes to eliminate debt and recapitalize balance sheet.
  • Aim to support commercialization and operational sustainability to cash flow break-even.
  • Significant distribution network across 15 countries.
  • Expansion of SaaS offerings for long-term value.
  • Commitment to data governance to support AI deployment in healthcare.
  • Fully funded business post-transaction with no debt.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.